VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
1.290
+0.010 (0.78%)
Jun 3, 2026, 9:41 AM EDT - Market open
VivoSim Labs Employees
VivoSim Labs had 14 employees as of December 31, 2025. The number of employees did not change compared to the same quarter last year.
Employees
14
Change
n/a
Growth
n/a
Revenue / Employee
$10,143
Profits / Employee
-$87,643
Market Cap
3.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | 0 | - | 14 | 0 |
| Sep 30, 2025 | 13 | -6 | -31.58% | 13 | 0 |
| Jun 30, 2025 | 13 | -7 | -35.00% | 13 | 0 |
| Mar 31, 2025 | 13 | -7 | -35.00% | 5 | 8 |
| Dec 31, 2024 | 14 | -4 | -22.22% | 14 | 0 |
| Sep 30, 2024 | 19 | -4 | -17.39% | 19 | 0 |
| Jun 30, 2024 | 20 | -3 | -13.04% | 20 | 0 |
| Mar 31, 2024 | 20 | -4 | -16.67% | 12 | 8 |
| Dec 31, 2023 | 18 | -2 | -10.00% | 18 | 0 |
| Sep 30, 2023 | 23 | 3 | 15.00% | 23 | 0 |
| Jun 30, 2023 | 23 | 4 | 21.05% | 23 | 0 |
| Mar 31, 2023 | 24 | 6 | 33.33% | 15 | 9 |
| Dec 31, 2022 | 20 | 8 | 66.67% | 20 | 0 |
| Sep 30, 2022 | 20 | 9 | 81.82% | 20 | 0 |
| Jun 30, 2022 | 19 | 10 | 111.11% | 19 | 0 |
| Mar 31, 2022 | 18 | 9 | 100.00% | 9 | 9 |
| Dec 31, 2021 | 12 | 5 | 71.43% | 12 | 0 |
| Sep 30, 2021 | 11 | 5 | 83.33% | 11 | 0 |
| Jun 30, 2021 | 9 | 3 | 50.00% | 9 | 0 |
| Mar 31, 2021 | 9 | 3 | 50.00% | 4 | 5 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Virax Biolabs Group | 19 |
| Azitra | 13 |
| TransCode Therapeutics | 12 |
| Decoy Therapeutics | 11 |
| Revelation Biosciences | 9 |
| Alzamend Neuro | 6 |
| Galmed Pharmaceuticals | 6 |
| Adial Pharmaceuticals | 5 |
VIVS News
- 5 weeks ago - VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing - GlobeNewsWire
- 2 months ago - VivoSim Announces Pricing of up to a $4 Million Public Offering - GlobeNewsWire
- 2 months ago - VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs - GlobeNewsWire
- 3 months ago - VivoSim appoints Arumugham Raghunathan as VP, global sales - TheFly
- 3 months ago - VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales - GlobeNewsWire
- 4 months ago - VivoSim to debut antibody drug conjugate data at SOT meeting - TheFly
- 4 months ago - VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego - GlobeNewsWire
- 4 months ago - VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China - GlobeNewsWire